Mylan Takes $76M Antitrust Verdict To High Court
Mylan Laboratories Inc. asked the U.S. Supreme Court in mid-June to review a $76 million antitrust verdict brought against it over licensing agreements for two anti-anxiety medications, claiming the plaintiffs, four...To view the full article, register now.
Already a subscriber? Click here to view full article